Medical Weight Loss, Led by a Board-Certified Obesity Medicine Physician

For in-network patients (Premera Blue Cross and other carriers as they come online), clinical visits with Dr. Farook are typically covered. The program enrollment fee covers services insurance doesn't typically pay for — body composition tracking, prior authorization support, the Aesthetic Restoration Credit, direct messaging access, and the nutrition framework. We verify your benefits before your first visit.

Coverage varies by plan. Some Premera plans cover GLP-1s for weight management with prior authorization; others don't. Some require you to meet specific BMI or comorbidity criteria. We submit and follow up on prior authorizations on your behalf. If your plan doesn't cover medication, we help you find the most affordable cash-pay option at retail pharmacy.

Wegovy and Ozempic are both semaglutide; Zepbound and Mounjaro are both tirzepatide. Wegovy and Zepbound are FDA-approved for weight loss; Ozempic and Mounjaro are approved for type 2 diabetes but sometimes prescribed off-label. Dr. Farook recommends the right medication for you based on your medical history, goals, and insurance coverage.

Most patients see meaningful weight loss within 8-12 weeks of starting GLP-1 therapy. Average weight loss on these medications is 15-22% of starting body weight over 12-18 months, but individual results vary based on biology, dosing, lifestyle factors, and treatment plan. We set realistic expectations at your first visit.

Side effects from GLP-1 medications — most commonly nausea, fatigue, or constipation — are why structured medical oversight matters. Most side effects are dose-related and can be managed by adjusting your titration schedule. We respond to side effect questions through direct messaging and adjust your treatment plan as needed.

This is one of the most important clinical issues with GLP-1 therapy. Up to 25-40% of weight lost on these medications can be lean muscle without intervention. Our program emphasizes protein adequacy, resistance training guidance, and quarterly body composition tracking to identify and address muscle loss early. Preserved muscle is the single biggest predictor of whether weight loss lasts.

Yes. Not every patient needs or wants medication. The program structure supports any medical weight loss approach Dr. Farook recommends — including non-medication strategies for patients who don't qualify for or prefer not to use GLP-1s.

Most patients transition to less frequent maintenance care — quarterly or twice-yearly visits with Dr. Farook to support long-term weight stability. Some patients renew for a second program year. We discuss options at month 11 so the transition is planned, not abrupt.

The program is designed as a 12-month commitment because that's the timeframe where sustainable weight loss results actually develop. We don't offer early cancellation except for serious life changes — documented medical issues, pregnancy, or relocation outside our service area. Payment plans (through Cherry financing) make the program accessible without requiring upfront payment.

That's a great way to start. The Medical Weight Loss Consultation ($250 cash-pay, or insurance-covered for in-network patients) gives you a full medical evaluation with Dr. Farook and a personalized treatment plan. You can decide whether to enroll in the program after that visit — there's no pressure to commit at consultation.

We do not recommend or offer compounded medications. The cleaner, safer, more clinically supported path is brand-name medication through your pharmacy.

Three things. Dr. Farook is board-certified in obesity medicine — a credential most weight loss clinic providers don't have. We're in-network with insurance, which means accessibility most cash-pay clinics can't match. And we track muscle preservation, hormone health, and metabolic markers as part of every program — not just the number on the scale.